Effects of hypochlorite and hydrogen peroxide on cardiac autonomic receptors and vascular endothelial function

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 4, 2003, Pages 249-253

  Sand, Carsten ^a,b   Peters, Stephan L M ^a   Pfaffendorf, Martin ^a   Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

1 adrenoceptor; Endothelium; Hydrogen peroxide; Hypochlorite; Left rat atrium; Muscarinic M2 receptor

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CHLORIDE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HEART RECEPTOR; HYDROGEN PEROXIDE; HYPOCHLORITE; ISOPRENALINE; METHOXAMINE; MUSCARINIC M2 RECEPTOR; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HEART; MALE; NONHUMAN; OXIDATION; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; AORTA, THORACIC; CHOLINERGIC AGONISTS; DEPRESSION, CHEMICAL; ENDOTHELIUM, VASCULAR; HEART ATRIA; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; MALE; METHOXAMINE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OXIDANTS; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0037393148     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03822.x     Document Type: Article

References (32)

1. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000; 18: 655-73.
2. Heinecke JW. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 1999; 133: 321-5.
3. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 1980; 93: 480-9.
4. Weiss SJ. Tissue destruction by neutrophils. N. Engl. J. Med. 1989; 320: 365-76.
5. 2/halide system in human atherosclerotic lesions: Colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem. 2000; 267: 4495-503.
6. Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 1976; 25: 1371-4.
7. Klebanoff SJ. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 1968; 95: 2131-8.
8. Jaimes AJ, Sweeney C, Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 2001; 38: 877-83.
9. Zhang C, Patel R, Eiserich JP et al. Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am. J. Physiol. Heart Circ. Physiol. 2001; 281: H1469-75.
10. Mian KB, Martin W. Hydrogen peroxide-induced impairment of reactivity in rat isolated aorta: Potentiation by 3-amino-1,2,4 triazole. Br. J. Pharmacol. 1997; 121: 813-19.
11. Okabe E, Takahashi S, Norisue M et al. The effect of hypochlorous acid and hydrogen peroxide on coronary flow and arrhythmogenesis in myocardial ischemia and reperfusion. Eur. J. Pharmacol. 1993; 248: 33-9.
12. Raschke P, Becker BF, Leipert B, Schwartz LM, Zahler S, Gerlach E. Postischemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid. Basic Res. Cardiol. 1993; 88: 321-39.
13. Peters SL, Pfaffendorf M, van Zwieten PA. Influence of oxidative stress on various inotropic responses in isolated rat left atria. Naunyn Schmiedebergs Arch. Pharmacol. 1997; 355: 390-7.
14. 1-adrenoceptor agonists in rat isolated atria after exposure to free radicals. Br. J. Pharmacol. 1998; 123: 952-8.
15. 2-muscarinic receptor stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 2001; 364: 166-71.
16. Zhang R, Brennan ML, Fu X et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2154-6.
17. Hazell LJ, Baernthaler G, Sotcker R. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic. Biol. Med. 2001; 31: 1254-62.
18. Lee YM, Hsiao G, Chen HR, Chen YC, Sheu JR, Yen MH. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Eur. J. Pharmacol. 2001; 422: 159-67.
19. Clerk A, Bogoyevitch MA, Andersson MB, Sugden PH. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 1994; 269: 32 848-57.
20. Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ, Sugden PH. Regulation of Ras-GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. J. Biol. Chem. 1999; 274: 19 762-70.
21. B pathways. Mol. Cell. Biochem. 1999; 202: 47-52.
22. Quist E, Powell P, Vasan R. Guanylnucleotide specificity for muscarinic receptor inhibitory coupling to cardiac adenylate cyclase. Mol. Pharmacol. 1992; 41: 177-84.
23. + channels in isolated pacemaker cells of the mammalian heart. Nature 1983; 303: 250-3.
24. 2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 1987; 238: 672-5.
25. Nathanson NM. Molecular properties of the muscarinic acetylcholine receptor. Annu. Rev. Neurosci. 1987; 10: 195-236.
26. Lasley RD, Mentzer Jr RM. Pertussis toxin blocks adenosine A1 receptor mediated protection of the ischemic rat heart. J. Mol. Cell. Cardiol. 1993; 25: 815-21.
27. Pfaffendorf M, van Zwieten PA. Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein. Br. J. Pharmacol. 1993; 108: 132-8.
28. Midwinter RG, Vissers MCM, Winterbourn CC. Hypochlorite acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch. Biochem. Biophys. 2001; 394: 13-20.
29. She ZW, Wewers MD, Herzyk DJ, Sagone AL, Davis WB. Tumor necrosis factor primes neutrophils for hypochlorous acid production. Am. J. Physiol. 1989; 257: L338-45.
30. Kalyanaraman B, Sohnle PG. Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants. J. Clin. Invest. 1985; 75: 1618-22.
31. Leake SD. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions. Atherosclerosis 1997; 129: 149-57.
32. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants in atherosclerosis Free Radic. Biol. Med. 2000; 28: 1717-25.